Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations.
Sheu WH, Rosman A, Mithal A, Chung N, Lim YT, Deerochanawong C, Soewondo P, Lee MK, Yoon KH, Schnell O. Sheu WH, et al. Among authors: deerochanawong c. Diabetes Res Clin Pract. 2011 Jun;92(3):312-21. doi: 10.1016/j.diabres.2011.04.019. Epub 2011 May 24. Diabetes Res Clin Pract. 2011. PMID: 21605924 Review.
Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors.
Mu YM, Misra A, Adam JM, Chan SP, Chow FC, Cunanan EC, Deerochanawong C, Jang HC, Khue NT, Sheu WH, Tan KE. Mu YM, et al. Among authors: deerochanawong c. Diabetes Res Clin Pract. 2012 Feb;95(2):179-88. doi: 10.1016/j.diabres.2011.09.023. Epub 2011 Oct 22. Diabetes Res Clin Pract. 2012. PMID: 22019271 Review.
The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice.
Reutens AT, Hutchinson R, Van Binh T, Cockram C, Deerochanawong C, Ho LT, Ji L, Khalid BA, Kong AP, Lim-Abrahan MA, Tan CE, Tjokroprawiro A, Yoon KH, Zimmet PZ, Shaw JE. Reutens AT, et al. Among authors: deerochanawong c. Diabetes Res Clin Pract. 2012 Oct;98(1):38-45. doi: 10.1016/j.diabres.2012.06.002. Epub 2012 Jul 10. Diabetes Res Clin Pract. 2012. PMID: 22784926 Clinical Trial.
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort.
Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, Aravind SR, Sheu W, Nguyen TK, Ozaki R, Deerochanawong C, Tsang CC, Chan WB, Hong EG, Do TQ, Cheung Y, Brown N, Goh SY, Ma RC, Mukhopadhyay M, Ojha AK, Chakraborty S, Kong AP, Lau W, Jia W, Li W, Guo X, Bian R, Weng J, Ji L, Reyes-dela Rosa M, Toledo RM, Himathongkam T, Yoo SJ, Chow CC, Ho LL, Chuang LM, Tutino G, Tong PC, So WY, Wolthers T, Ko G, Lyubomirsky G, Chan JC. Yeung RO, et al. Among authors: deerochanawong c. Lancet Diabetes Endocrinol. 2014 Dec;2(12):935-43. doi: 10.1016/S2213-8587(14)70137-8. Epub 2014 Jul 28. Lancet Diabetes Endocrinol. 2014. PMID: 25081582
A patient-centric approach to optimise insulin therapy in Asia.
Goh SY, Ang E, Bajpai S, Deerochanawong C, Hong EG, Hussein Z, Joshi S, Kamaruddin NA, Kho S, Kong AP, Pan CY, Perfetti R, Vichayanrat A, Vlajnic A, Chan JC. Goh SY, et al. Among authors: deerochanawong c. J Diabetes Complications. 2016 Aug;30(6):973-80. doi: 10.1016/j.jdiacomp.2016.05.019. Epub 2016 May 24. J Diabetes Complications. 2016. PMID: 27288201 No abstract available.
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
Bain SC, Mosenzon O, Arechavaleta R, Bogdański P, Comlekci A, Consoli A, Deerochanawong C, Dungan K, Faingold MC, Farkouh ME, Franco DR, Gram J, Guja C, Joshi P, Malek R, Merino-Torres JF, Nauck MA, Pedersen SD, Sheu WH, Silver RJ, Tack CJ, Tandon N, Jeppesen OK, Strange M, Thomsen M, Husain M. Bain SC, et al. Among authors: deerochanawong c. Diabetes Obes Metab. 2019 Mar;21(3):499-508. doi: 10.1111/dom.13553. Epub 2018 Nov 11. Diabetes Obes Metab. 2019. PMID: 30284349 Free PMC article. Clinical Trial.
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
Deerochanawong C, Chan SP, Matawaran BJ, Sheu WH, Chan J, Man NH, Suastika K, Khoo CM, Yoon KH, Luk A, Mithal A, Linong J. Deerochanawong C, et al. Diabetes Obes Metab. 2019 Nov;21(11):2354-2367. doi: 10.1111/dom.13819. Epub 2019 Jul 17. Diabetes Obes Metab. 2019. PMID: 31264765 Free PMC article. Review.
134 results